Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q784717> ?p ?o }
Showing triples 1 to 56 of
56
with 100 triples per page.
- Q784717 subject Q8252305.
- Q784717 subject Q8297717.
- Q784717 subject Q8533683.
- Q784717 subject Q8852392.
- Q784717 abstract "Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed in the United States as Teveten by Abbvie, the spin-off of the pharmaceutical discovery division of Abbott Laboratories; it is marketed as Eprozar by INTAS Pharmaceuticals in India, and by Abbott Laboratories elsewhere. The compound came into the Abbott Laboratories cardiovascular pipeline with its acquisition of Kos Pharmaceuticals in 2006, which had licensed it, along with "a range of hypertensive treatments", from the Biovail Corporation.Eprosartan is sometimes paired with hydrochlorothiazide, whereupon it is marketed in the US as Teveten HCT and elsewhere as Teveten Plus.The drug acts on the renin-angiotensin system to decrease total peripheral resistance in two ways. First, it blocks the binding of angiotensin II to AT1 receptors in vascular smooth muscle, causing vascular dilatation. Second, it inhibits sympathetic norepinephrine production, further reducing blood pressure.As with other angiotensin II receptor antagonists, eprosartan is generally better tolerated than enalapril (an ACE inhibitor), especially among the elderly.".
- Q784717 atcPrefix "C09".
- Q784717 atcSuffix "CA02".
- Q784717 bioavailability "15.0".
- Q784717 casNumber "133040-01-4".
- Q784717 chEBI "4814".
- Q784717 drugbank "DB00876".
- Q784717 fdaUniiCode "2KH13Z0S0Y".
- Q784717 iupacName "4-({2-Butyl-5-[2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid".
- Q784717 pubchem "5281037".
- Q784717 thumbnail Eprosartan.svg?width=300.
- Q784717 wikiPageWikiLink Q1186164.
- Q784717 wikiPageWikiLink Q14662364.
- Q784717 wikiPageWikiLink Q14859647.
- Q784717 wikiPageWikiLink Q186242.
- Q784717 wikiPageWikiLink Q187215.
- Q784717 wikiPageWikiLink Q208453.
- Q784717 wikiPageWikiLink Q285044.
- Q784717 wikiPageWikiLink Q288280.
- Q784717 wikiPageWikiLink Q30.
- Q784717 wikiPageWikiLink Q306764.
- Q784717 wikiPageWikiLink Q41861.
- Q784717 wikiPageWikiLink Q422185.
- Q784717 wikiPageWikiLink Q423930.
- Q784717 wikiPageWikiLink Q456026.
- Q784717 wikiPageWikiLink Q5281995.
- Q784717 wikiPageWikiLink Q668.
- Q784717 wikiPageWikiLink Q8252305.
- Q784717 wikiPageWikiLink Q8297717.
- Q784717 wikiPageWikiLink Q851111.
- Q784717 wikiPageWikiLink Q8533683.
- Q784717 wikiPageWikiLink Q864903.
- Q784717 wikiPageWikiLink Q8852392.
- Q784717 wikiPageWikiLink Q898218.
- Q784717 wikiPageWikiLink Q9377.
- Q784717 atcPrefix "9.0".
- Q784717 atcSuffix "CA02".
- Q784717 bioavailability "15.0".
- Q784717 casNumber "133040".
- Q784717 chebi "4814".
- Q784717 drugbank "DB00876".
- Q784717 iupacName "4".
- Q784717 pubchem "5281037".
- Q784717 unii "2".
- Q784717 type ChemicalSubstance.
- Q784717 type Drug.
- Q784717 type ChemicalObject.
- Q784717 type Thing.
- Q784717 type Q8386.
- Q784717 comment "Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed in the United States as Teveten by Abbvie, the spin-off of the pharmaceutical discovery division of Abbott Laboratories; it is marketed as Eprozar by INTAS Pharmaceuticals in India, and by Abbott Laboratories elsewhere.".
- Q784717 label "Eprosartan".
- Q784717 depiction Eprosartan.svg.